This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Formycon AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €3.657. Formycon AG's 10-Year median PS Ratio is 20.4184. Therefore, the Median PS Value for today is €74.67.
As of today (2024-12-15), Formycon AG's share price is €52.80. Formycon AG's Median PS Value is €74.67. Therefore, Formycon AG's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Formycon AG's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of Formycon AG was 1.83. The lowest was 0.76. And the median was 1.30.
XTER:FYB's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.7 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Formycon AG Median PS Value Historical Data
The historical data trend for Formycon AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Formycon AG's Median PS Value
For the Biotechnology subindustry, Formycon AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Formycon AG's Price-to-Median-PS-Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Formycon AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Formycon AG's Price-to-Median-PS-Value falls into.
Formycon AG Median PS Value Calculation
Formycon AG's Median PS Value for today is calculated as
10-Year Median PS Ratio is 20.4184.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Formycon AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €3.657.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Formycon AG (XTER:FYB) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Formycon AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
52.80
/
74.67
=
0.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Formycon AG Median PS Value Related Terms
Thank you for viewing the detailed overview of Formycon AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID-19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:FYB has been successfully added to your 